Founded in San Diego, REVA Medical is dedicated to restoring patient health through the development and sale of bio-resorbable polymers for vascular applications. The company's core mission is to leverage advanced biomaterials to create implantable medical devices that improve long-term patient outcomes. Their flagship product, the Fantom bioresorbable coronary artery scaffold, exemplifies their commitment to innovative solutions in cardiovascular health.
REVA Medical has garnered attention from notable investors and industry leaders, contributing to its strategic growth and development. The company has achieved significant milestones, including the successful completion of the FANTOM II trial and the initiation of the MOTIV IDE clinical trial. These accomplishments underscore REVA Medical's impact on advancing vascular health technologies and improving patient care worldwide.
